The U.S. Food & Drug Administration (FDA) achieved a “milestone” by issuing an emergency use authorization (EUA) for a self-administered test that can “differentiate and detect” influenza and SARS-CoV-2.
Call me skeptical based on the faulty PCR tests they rammed up millions of noses the past three years.
U.S. FDA issues emergency use authorization (EUA) for the “first over-the-counter (OTC) at-home diagnostic test” that can “differentiate” and “detect” influenza A and B, commonly known as the flu, and SARS-CoV-2
Sure it does….Just like those PCR tests accurately detected C-19.
— DailyNoah.com (@DailyNoahNews) February 27, 2023
Fraudulent PCR Tests EXPOSED! CDC Quietly Withdraws Emergency Use Authorization Due to Inability to Differentiate COVID-19 & Influenza
First off, those nasal swabs can cause damage.